Canaccord initiated coverage of Achieve Life Sciences (ACHV) with a Buy rating and $13 price target
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHV:
- Achieve Life Sciences Raises Capital, Appoints New CEO
- Achieve Life Sciences announces $354M private placement
- Achieve Life Sciences appoints Goldberg as CEO, names two leaders to board
- Achieve Life Sciences Maps High‑Stakes Path To 2027
- Regulatory Fears Overdone: CMC-Driven Volatility Creates Attractive Entry Point Ahead of 2027 Cytisinicline Launch